Thierry Hercend

Venture Partner, Life Sciences Team at Andera Partners

Thierry is currently Chairman of the board of Inotrem and GamaMabs and he is a member of the board of Poxel, Grey Wolf Therapeutics and Complix. He was also a board member of U3 Pharma and PegaOne, and Chairman of the board of Oncoethix until their acquisition by large pharmaceutical companies.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Andera Partners

ANDERA PARTNERS, was created in 2001 and is a leader in investments in unlisted companies in France and internationally. It manages over €2 billion in investments in life sciences (BioDiscovery), growth capital and OBO (Winch Capital for midcap and Cabestan Capital for small-cap) and sponsorless mezzanine debt.


Industries

Headquarters

Paris, France

Employees

51-200

Links